文献速递泌尿生殖妇产影像US

初级放射科医生应用O-RADS US(2019版与2022版)并结合声影诊断附件肿块的诊断效能:1061个附件肿块分析

Diagnostic Performance of O-RADS US (Version 2019 and Version 2022) Incorporating Acoustic Shadowing by Junior Radiologists: Analyzing 1061 Adnexal Masses.
PubMed 文献 · J Ultrasound Med · 2025-01-10

这项回顾性研究纳入1015例女性共1061个附件肿块,由初级医生按O-RADS US 2019版和2022版分类,并评估将声影作为良性特征加入2019版的价值。O-RADS 2019版和2022版的AUC分别为0.920和0.924,加入声影的改良模型AUC为0.934,较2019版提高特异度5.4%;以改良O-RADS 4类为恶性的最佳截断值,敏感度94.4%、特异度81.6%。

要点

  • O-RADS US 2019版与2022版对附件肿块诊断的AUC分别为0.920和0.924,均表现优秀。
  • 将声影作为良性特征加入2019版后,AUC提高至0.934,特异度较2019版的76.2%提高5.4%。
  • 以改良O-RADS 4类为恶性最佳截断值,敏感度94.4%、特异度81.6%。

核心结论

  • O-RADS US对附件肿块诊断表现优秀;将声影作为良性特征加入O-RADS US 2019版可提高诊断效能,较2019版特异度76.2%提高5.4%。

研究设计与样本

  • 回顾性研究,纳入2022年9月至2024年1月连续接受超声检查的疑诊附件肿块女性,共1015例女性1061个附件肿块,由一名2年经验的初级医生按2019版和2022版O-RADS US分类。

诊断标准与关键数值

  • O-RADS US 2019版AUC 0.920(95%CI 0.902–0.936,P<.001),2022版AUC 0.924(95%CI 0.906–0.939,P<.001),加入声影的改良模型AUC 0.934(95%CI 0.917–0.948,P<.001),改良模型与两版O-RADS的AUC差异有统计学意义(P<.005);以改良O-RADS 4类为恶性最佳截断值,敏感度94.4%(95%CI 90.2%–97.2%)、特异度81.6%(95%CI 78.8%–84.1%)、阳性预测值53.9%(95%CI 50.3%–57.5%)、阴性预测值98.5%(95%CI 97.3%–99.1%)。

临床应用与阅片要点

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

INTRODUCTION: Acoustic shadowing is an important benign ultrasound (US) feature for adnexal masses (AMs). To validate the diagnostic performance and interobserver agreement of the 2019 version and 2022 version of Ovarian-Adnexal Reporting and Data System Ultrasound (O-RADS US) and ascertain whether adding acoustic shadowing to O-RADS US v2019 as a benign ultrasound feature can enhance its diagnostic efficacy among junior radiologist.

METHODS: This retrospective study included consecutive women with suspected adnexal masses who underwent ultrasound examinations between September 2022 and January 2024. One junior doctor (Reader 1, 2 years of experience) classified each AM according to the O-RADS US v2019 and the v2022. Lesions were reclassified according to the US features of acoustic shadowing based on the O-RADS US v2019: the O-RADS category was downgraded by one level with acoustic shadowing and remained unchanged without acoustic shadowing for categories 2-5. Receiver operating characteristic (ROC) curve analysis was used to evaluate the diagnostic performance of the two versions of O-RADS and the modified O-RADS model. Two independent junior radiologists (Reader 1 and Reader 2 with 3 years of experience) then classified the 200 AMs randomly selected for a test-retest analysis. Kappa (к) statistics were used to assess the interobserver agreement.

RESULTS: Overall, 1015 women (range, 16-86 years) with 1061 AMs were evaluated. Of the lesions, 864 (81.4%) were benign and 197 (18.6%) were malignant. The area under the ROC curve (AUC) for O-RADS v2019 and v2022 were 0.920 (95% confidence interval [CI]: 0.902, 0.936, P < .001) and 0.924 (95% CI: 0.906, 0.939, P < .001), respectively. The modified model based on O-RADS v2019 incorporating acoustic shadowing as a benign US feature showed an improved AUC of 0.934 (95% CI: 0.917, 0.948, P < .001). A significant difference was observed between the AUCs of the modified O-RADS and two versions of O-RADS models (P < .005). The inclusion of acoustic shadowing increased specificity by 5.4% in predicting malignant adnexal masses, compared with the O-RADS US v2019 with a specificity of 76.2%. Using the modified O-RADS category 4 as the optimal cut-off value for predicting malignancy showed a sensitivity, specificity, positive predictive value, and negative predictive value were 94.4% (95% CI: 90.2%, 97.2%), 81.6% (95% CI: 78.8%, 84.1%), 53.9% (95% CI: 50.3%, 57.5%), and 98.5% (95% CI: 97.3%, 99.1%), respectively. The inter-observer agreement in the O-RADS category between these two junior radiologists was good (κ = 0.74, P < .001).

CONCLUSION: We validated the excellent performance of the Ovarian-Adnexal Reporting and Data system Ultrasound for diagnosing adnexal masses, and the inclusion of acoustic shadowing increased specificity by 5.4% in predicting malignant adnexal masses, compared with the O-RADS US v2019 with the specificity of 76.2%.

来源:J Ultrasound Med,查看原文。版权归原作者所有。

引用

  1. Wu C, Wu L, Shang J, et al. Diagnostic Performance of O-RADS US (Version 2019 and Version 2022) Incorporating Acoustic Shadowing by Junior Radiologists: Analyzing 1061 Adnexal Masses. J Ultrasound Med. 2025. PMID: 39791550. doi:10.1002/jum.16644

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。